WHO SMART Guidelines - HIV
0.3.0 - ci-build

WHO SMART Guidelines - HIV - Local Development build (v0.3.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

PlanDefinition: PlanDefinition - Care and treatment clinical visit (Experimental)

Official URL: http://smart.who.int/hiv/PlanDefinition/CareAndTreatmentClinicalVisit-PlanDefinition Version: 0.3.0
Active as of 2024-12-06 Computable Name: PlanDefinition_Care and treatment clinical visit

To initiate ART and to provide HIV care, treatment and integrated health services

Id: CareAndTreatmentClinicalVisit-PlanDefinition
Url: PlanDefinition - Care and treatment clinical visit
Version: 0.3.0
Title: PlanDefinition - Care and treatment clinical visit
Experimental: true
Type:

system: http://terminology.hl7.org/CodeSystem/plan-definition-type

code: workflow-definition

display: Workflow Definition

Date: 2024-12-06 22:28:12+0000
Publisher: WHO
Description:

To initiate ART and to provide HIV care, treatment and integrated health services

Actions:
Care and treatment clinical visit business process: To initiate ART and to provide HIV care, treatment and integrated health services
Then:
Determine reason for visit: Search for client details in the system and determine reason for visit
Take vital signs: Also record weight, height, etc. For children, weight will be needed to determine dosage and to check for malnutrition.
Check for signs of serious illness: Any person who has signs of seriously illness should be referred to the appropriate higher-lever facility for management
Screen for TB : Adults and adolescents living with HIV should be screened for TB according to a clinical algorithm
Seriously ill?: Any person who has signs of serious illness should be referred to the appropriate higher-lever facility for management or receive emergency care, depending on availability and policies.
Capture or update client history: Discuss history with client and review available records. History-taking should include partner’s HIV status and whether the partner is virally suppressed on ART
First time initiating treatment?: This step checks whether the client is naïve to ART
Counsel returning clients: Adherence, such as whether client is picking up meds and/or has any barriers to adherence to their treatment(s), if so, set plan for adherence support
Retest for HIV using testing algorithm: WHO recommends that all programmes retest people diagnosed with HIV prior to initiating lifelong ART
Determine recommended screenings and tests: HIV.D12.DT Determine recommended screenings and tests
Examine client: Examine the client clinically, with a physical exam
Prevent, screen and manage comorbidities and coinfections: With ART, HIV is a chronic disease requiring lifetime care. WHO guidelines cover information on common and important concomitant conditions among people living with HIV, including: co-trimoxazole prophylaxis; the diagnosis, prevention and treatment of TB, viral hepatitis, malaria, sexually transmitted infections, cervical cancer prevention, nutrition, vaccinations, mental health and substance use
Determine clinical stage of HIV: HIV.D15.DT Determine WHO clinical stage of HIV
Perform other screenings: Conduct screenings based on recommendations and priorities and depending on the diagnostics that are available.
Check for signs of treatment failure: Review new diagnostic results
Diagnostics: Viral load should be tested routinely for early warning of virological failure and monitored if clinical or virological failure are suspected
Determine regimen and treatment options: For continuing care, check the dosage and need for readjustment or whether treatment failure is suspected.
Make informed decision on treatment: Even if client is eligible to start ART, the choice to accept or decline ART ultimately lies with the person or his or her caregiver, and if the decision is to defer initiation, ART can be offered again at subsequent visits
Prescribe: The scripting period should cover the period until the next clinical consultation (not until the following ART refill visit).
Counsel: Counsel clients on adherence.
Laboratory diagnostics needed: Additional testing or specimen collection may be needed and may happen after the visit